Gsk Plc ADR (GSK)

$39.60 0.33 (0.84%)

12:50 EDT GSK Stock Quote Delayed 30 Minutes

3 Low-Priced Dividend Stocks With Solid Fundamentals & Growth

By Larry Ramer, InvestorPlace Contributor Feb 21, 2024

Solid dividend stocks with good growth outlooks can deliver high profits for investors and should become more popular as interest rates drop.

The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024

3 Hidden Healthcare Stocks Poised for a Breakout This Year

The Cutting Edge: 3 Stocks to Buy for the Next Generation of Biotech Breakthroughs

Volume:

Previous Close -

Market Cap 213.25B

PE Ratio -

EPS -

Volume (Avg. Vol.) 828,984

Day's Range $39.37 - $39.75

52-Week Range $33.33 - $43.84

Dividend & Yield $1.44 (3.65%)

GSK Stock Predictions, Articles, and Gsk Plc ADR News

From InvestorPlace
From the Web

Sleeper Hits: 3 Unexpected Stocks Poised for a Breakout in 2024

By Larry Ramer, InvestorPlace Contributor Jan 5, 2024

Many stocks emerge from Wall Street's doghouse relatively quickly. Here are three names that could become surprise breakout stocks for 2024.

3 Growth at a Reasonable Price (GARP) Stocks for Balanced Growth

By Larry Ramer, InvestorPlace Contributor Dec 22, 2023

GARP stocks are less likely to plunge than growth stocks with high valuations and more likely to generate strong growth than value stocks.

3 Stocks to Sell for Tax Losses Before the New Year

By Josh Enomoto, InvestorPlace Contributor Nov 28, 2023

Of course, the primary goal of betting in the equities sector is to make money, not to create a list of stocks to sell for…

3 Healthcare Stocks Getting Help From the Aging Population

By Larry Ramer, InvestorPlace Contributor Nov 6, 2023

America's aging population needs chronic conditions treatments, and these healthcare stocks are growing in the quest for healing solutions.

3 Top Dividend Stock Picks for Steady Income and Capital Appreciation

By Larry Ramer, InvestorPlace Contributor Nov 2, 2023

Conservative investors will benefit from these top dividend stock picks that are likely to generate significant returns.

3 Deeply Undervalued Growth Stocks to Buy in November

By Larry Ramer, InvestorPlace Contributor Oct 27, 2023

One of the New York Yankees' most well-known players', Yogi Berra, famous for his strange, yet funny statements, used to say, "This is deja vu…

7 ‘Smart Money’ Stocks Set to Explode Higher

By Muslim Farooque, InvestorPlace Contributor Sep 30, 2023

Invest like the pros by wagering on these top seven smart money stocks to buy at this time, offering tremendous upside ahead.

7 Stocks Hedge Funds Are Loading Up On

By Larry Ramer, InvestorPlace Contributor Sep 3, 2023

Hedge funds and many other financial institutions are loading up on these names which are among the top institutional stock picks.

3 Growth Stocks to Ride the Coming Bull Market in Style

By Rich Duprey, InvestorPlace Contributor Aug 26, 2023

Stocks are rallying once again in 2023. The growth-oriented index is leading the way higher with a 36% gain or more than twice the return…

3 Sorry Pharma Stocks to Sell in August Before It’s Too Late

By Tyrik Torres, InvestorPlace Contributor Aug 22, 2023

Factors in the marketplace caused these companies to underperform, making them some of the top pharma stocks to sell.

3 Pharma Stocks to Sell in August Before They Crash and Burn

By Joel Baglole, InvestorPlace Contributor Aug 11, 2023

Stay far away from these pharma stocks that are suffering from declining sales and weak pipelines of future products.

If You Can Only Buy One Dividend Stock, It Better Be One of These 7 Names

By Larry Ramer, InvestorPlace Contributor Jul 30, 2023

These seven best dividend stocks will eventually rally and they will pay investors to wait for them to do so.

3 Millionaire-Maker Biotech Stocks to Buy Before the Window Closes

By Larry Ramer, InvestorPlace Contributor Jul 30, 2023

Here are three millionaire maker drug stocks from companies whose drugs could make truly staggering profits.

The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023

By Charles Munyi, InvestorPlace Contributor Jul 21, 2023

Trading below a 15 forward price-to-earnings, these undervalued pharma stocks offer opportunities in an overbought market.

7 Healthcare Stocks to Make You the Millionaire Next Door

By Larry Ramer, InvestorPlace Contributor Jun 21, 2023

For investors who want to greatly increase their wealth in the long term, these are the best healthcare stocks to buy.

3 Personalized Medicine Stocks to Buy for Long-Time Returns

By John Blankenhorn, InvestorPlace Contributor May 15, 2023

Personalized medicine is the future of medicine. Here are three personalized medicine stocks to invest in so you don't miss out.

GSK Stock: A Value Trap or a Hidden Gem?

By Samuel O'Brient, InvestorPlace Reporter Apr 27, 2023

GSK, formerly known as GlaxoSmithKline, is struggling after a complicated earnings season. Here's why GSK stock is still a buy.

Why Is Bellus Health (BLU) Stock Up 98% Today?

By William White, InvestorPlace Writer Apr 18, 2023

Bellus Health (BLU) stock is taking off on Tuesday after the company announced a $2 billion acquisition deal with GSK (GSK).

Why Is Scynexis (SCYX) Stock Up 69% Today?

By William White, InvestorPlace Writer Mar 30, 2023

Scynexis (SCYX) stock is taking off on Tuesday as investors react to news of an exclusive license agreement for Brexafemme.

3 Pharma Stocks That Could Benefit from Global Healthcare Trends

By Larry Ramer, InvestorPlace Contributor Mar 17, 2023

The best pharma stocks to buy are those that are poised to be greatly boosted by drugs that are well-positioned to become blockbusters.

Gsk Plc ADR (GSK)

3 Low-Priced Dividend Stocks With Solid Fundamentals & Growth

The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024

3 Hidden Healthcare Stocks Poised for a Breakout This Year

The Cutting Edge: 3 Stocks to Buy for the Next Generation of Biotech Breakthroughs

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Gsk Plc ADR (GSK)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

GSK Stock Predictions, Articles, and Gsk Plc ADR News

Subscriber Sign in